Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...
Príomhchruthaitheoirí: | Psarros, C, Lee, R, Margaritis, M, Antoniades, C |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2012
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
de réir: Psarros, C, et al.
Foilsithe / Cruthaithe: (2012) -
Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
de réir: Psarros, C, et al.
Foilsithe / Cruthaithe: (2012) -
Nanomedicine for Diagnosis and Treatment of Atherosclerosis
de réir: Jingyun Cheng, et al.
Foilsithe / Cruthaithe: (2023-12-01) -
Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
de réir: Shuihua Zhang, et al.
Foilsithe / Cruthaithe: (2020-01-01) -
The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
de réir: Antonopoulos, A, et al.
Foilsithe / Cruthaithe: (2010)